Soon after the introduction of coronary artery bypass surgery, the "completeness" of revascularization became a matter of concern. Several early surgical studies confirmed the belief that better clinical outcomes were obtained when each and every angiographically visible stenosis was bypassed by a distal anastomosis.
1,2 Similarly, among patients with multivessel disease treated with percutaneous coronary intervention (PCI), complete revascularization was found to provide a significant advantage over incomplete revascularization in terms of reintervention, myocardial infarction and death. 3, 4 However, a careful analysis of surgically treated multivessel disease patients in the BARI trial showed that one graft to any system other than the LAD confers no long-term advantage over PCI and may actually be deleterious. 5 More recently, the results of large surgical registries supported strategies of "reasonably incomplete" revascularization. [6] [7] [8] In addition, the FAME trial indicated that, in patients with multivessel disease, approximately one third of angiographically 'significant' stenoses were actually hemodynamically not significant. 9 Stenting limited to stenoses with a fractional flow reserve (FFR) value below 0.80 yielded better clinical outcomes than stenting based on treating every visible lesion , introducing the concept of "functionally complete" rather than "anatomically complete" revascularization.
Several factors contribute to the marked variability in prognostic value of "incomplete revascularization" reported. First, the definition of incomplete revascularization has varied from study to study 10 , making the results difficult to compare. Second, in all studies, the definition of incomplete revascularization was based on percent diameter stenoses derived from visual estimation. This simple metric is misleading, especially in coronary segments portending as high a prognostic value as the left main. 11 The poor correlation between the angiogram and the presence of vessel-related ischemia clouds the relationship between the degree of More recently, the results of large surgical registries supported strategies s o of f f "r "r " ea ea ea easo so so sona na na nabl b bl bly y ncomplete" revascularization. [6] [7] [8] In addition, the FAME trial indicated that, in patients with mu mult lt t ltiv iv iv ive e es esse se e sel l l l di di d d se eas as as ase e e, e, approximately one third of f an an an ang g gi iographically 'si s gn gn nif if if ifi i ic icant' stenoses were a ac ctu u u ual a ly hemod od d dy yn n na a am amic ic ic i al al al ll l ly ly n n not ot ot ot s sig ig g gni ni ni nifi fic c can n n nt. Since residual vessel-related ischemia is difficult to assess non-invasively, 12 especially early after an acute coronary syndrome, these patients are often discharged without knowing whether or not the non-culprit lesions are in fact hemodynamically significant.
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The results of this investigation may have significant consequences for our treatment strategy. They indicate -expectedly -that the more stringent the definition of incomplete revascularization, the lower its prevalence, and the higher the chance of any individual patients with incomplete revascularization to experience an event. More importantly, the data convincingly show that, irrespective of its definition, incomplete revascularization is associated with a significant increase in myocardial infarction and of repeat revascularization and a trend towards increased mortality. Even though the present study was limited to patients with NSTEMI-ACS, its conclusions are likely to be applicable to the full range of ACS, including ST elevation myocardial infarctions (STEMI). In patients with STEMI undergoing primary PCI in the HORIZONS-AMI trial, the presence of stenoses of more than 50% in non-infarct-related arteries was associated with a 40% relative increase in the risk of death at 3 years. When one of these non-infarct-related arteries happened to be a chronic occlusion, this risk was 2.5 times higher. 15 These results leave little doubt about the detrimental effect of extensive residual atherosclerosis.
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This simplification of the post-ACS diagnostic work-up would render non-invasive testing superfluous, since all the information needed for clinical decision making about additional revascularization will have been obtained in the catheterization laboratory.
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